Keywords
How to Cite
Abstract
The article presents long-term results of observation of patients operated on with papillary thyroid cancer. In the course of the work, through a comprehensive analysis of the clinical and morphological characteristics of papillary thyroid carcinoma and functional variants of the genes of the proteolysis system, the relationship of gene variants regulating the collagen degradation system with the features of the clinical course of papillary thyroid carcinoma in different age groups was established.
References
Бельцевич Д.Г., Ванушко В.Э., Румянцев П.О. и др. Российские клинические рекомендации по диагностике и лечению высокодифференцированного рака щитовидной железы у взрослых // Эндокринная хирургия. 2017;1(11):6–27 [Belcevich DG, Vanushko VE, Rumyantsev PO et al. Russian clinical guidelines for the diagnosis and treatment of highly differentiated thyroid cancer in adults // Endocrinnaya khirurgiya. 2017;1(11):6–27 (In Russ.)]. doi:10.14341/serg201716-27
Мерабишвили В.М. Злокачественные новообразования в Северо-Западном федеральном округе // Пособие для врачей. 2020 [Merabishvili V.M. Malignant neoplasms in the Northwestern Federal District. A guide for doctors. 2020 (In Russ.)].
Tuttle RM. Controversial Issues in Thyroid Cancer Management // J Nucl Med. 2018;59(8):1187–1194. doi:10.2967/jnumed.117.192559
Stewart LA, Kuo JH. Advancements in the treatment of differentiated thyroid cancer // Ther Adv Endocrinol Metab. 2021;12. doi:10.1177/20420188211000251
Хазиев В.В., Штандель С.А., Караченцев Ю.И. Распространенность рака щитовидной железы и факторы, влияющие на ее динамику // Проблемы эндокринологии. 2008;54(4):18–21 [Khaziev VV, Shtandel SA, Karachentsev YuI. Prevalence of thyroid cancer and factors affecting its dynamics // Problemy endocrinologii. 2008;54(4):18–21 (In Russ.)]. doi:10.14341/probl200854418-21
Teo KW, Yuan NK, Tan WB, Parameswaran R. Comparison of prognostic scoring systems in follicular thyroid cancer // Ann R Coll Surg Engl. 2017;99(6):479–484. doi:10.1308/rcsann.2017.0072
Glikson E, Alon E, Bedrin L, Talmi YP. Prognostic Factors in Differentiated Thyroid Cancer Revisited // Isr Med Assoc J. 2017;19(2):114–118.
Черников Р.А., Валдина Е.А., Воробьев С.Л. и др. Отдаленные результаты хирургического лечения при папиллярном раке щитовидной железы и сравнительная оценка тактики лечения // Клиническая и экспериментальная тиреоидология. 2014;10(1):31–31 [Chernikov RA, Valdina EA, Vorobjev SL et al. Long-term results of surgical treatment for papillary thyroid cancer and comparative assessment of treatment tactics // Clinicheskaya i eksperimentalnaya tireoidologiya. 2014;10(1):S31–31 (In Russ.)]. doi:10.14341/CET201410131-37
Zarkesh M, Zadeh-Vakili A, Azizi F et al. Altered epigenetic mechanisms in thyroid cancer subtypes // Mol Diagn Ther. 2018;22(1):41–56. doi:10.1007/s40291-017-0303-y:
Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma // Cell. 2014;159(3):676−690.
Patel KN, Angell TE, Babiarz J et al. Performance of a genomic sequencing classifier for the preoperative diagnosis of cytologically indeterminate thyroid nodules // JAMA Surg. 2018;153(9):817–824. doi:10.1001/jamasurg.2018.1153
Steward DL, Carty SE, Sippel RS et al. Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: a prospective blinded multicenter study // JAMA Oncol. 2019;5(2):204–212. doi:10.1001/jamaoncol.2018.4616
Morosova EB, Chukhlovin AB, Kulagina NV et al. Functional gene polymorphism of matrix metalloproteinase-1 is associated with benign hyperplasia of myo- and endometrium in the Russian population // Gen Testing Mol Biomarkers. 2012;16(9):1032–1037. doi:10.1089/gtmb.2011.0376
Wan J, Zhang G, Li X et al. Matrix metalloproteinase 3: A promoting and destabilizing factor in the pathogenesis of disease and cell differentiation // Front Physiol. 2021;12:663978. doi:10.3389/fphys.2021.663978
Balkhi S, Mashayekhi F, Salehzadeh A, Saedi HS. Matrix metalloproteinase (MMP)-1 and MMP-3 gene variations affect MMP-1 and -3 serum concentration and associates with breast cancer // Mol Biol Rep. 2020;47(12):9637–9644. doi:10.1007/s11033-020-05962-x
Frieling JS, Tao Li T, Tauro M. Prostate cancer-derived MMP-3 controls intrinsic cell growth and extrinsic angiogenesis // Neoplasia. 2020;22(10):511–521. 10.1016/j.neo.2020.08.004
Sartori MT, Danesin C, Saggiorato G et al. The PAI-1 gene 4G/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia // Clin Appl Thromb Hemost. 2003;9(4):299–307. doi:10.1177/107602960300900405
Sayed-Tabatabaei FA, Oostra BA, Isaacs A et al. ACE Polymorphisms // Circ Res. 2006;98(9):1123–1133. doi:10.1161/01.RES.0000223145.74217.e7
Романчишен А.Ф., Кузьмичев А.С., Богатиков А.А. и др. Клиническая значимость функциональных вариантов генов матриксных металлопротеиназ при раке щитовидной железы // Вестник хирургии. 2009;168(1):57–60 [Romanchishen AF, Kuzmichev AS, Bogatikov AA et al. Clinical significance of functional variants of matrix metalloproteinase genes in thyroid cancer // Vestnik khirurgii. 2009;168(1):57–60 (In Russ.)].
Hopps E, Lo Presti R, Caimi G. Matrix metalloproteases in arterial hypertension and their trend after antihypertensive treatment // Kidney Blood Press Res. 2017;42(2):347–357. doi:10.1159/000477785
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2022